Depression, Anxiety Clinical Trial
— STEP-UPOfficial title:
Behavioral Telehealth in Low-resource Primary Care Settings for Anxiety and Depression in Youth: A Randomized Effectiveness-implementation Study
Verified date | May 2024 |
Source | San Diego State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this clinical trial is to test a brief, behavioral telehealth treatment program (STEP-UP) for depression and anxiety in youths (age 8-16 years old). Youths and families will be recruited through participating community health centers and will be randomly assigned to either: (a) receive STEP-UP care from providers at their health center or (b) be referred to care from local community mental health clinicians. Youth and families will be interviewed before treatment starts, 16 weeks later, and 24 weeks later to assess how youth are feeling. The main question the study aims to answer is whether STEP-UP improves youths functioning in daily life, anxiety symptoms, and depression symptoms. Researchers will compare STEP-UP to referral to community treatment-as-usual mental health services to see if STEP-UP is more effective.
Status | Not yet recruiting |
Enrollment | 220 |
Est. completion date | May 31, 2028 |
Est. primary completion date | May 31, 2028 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 8 Years to 16 Years |
Eligibility | Inclusion Criteria: - Youth is a patient in a participating community health center. - Youths meet criteria for clinically significant anxiety and / or depression as indexed at baseline assessment by either: - research diagnosis of anxiety (Social Anxiety Disorder, Generalized Anxiety Disorder, Separation Anxiety Disorder) and / or depressive disorder (Major Depressive Disorder, Persistent Depressive Disorder). - scores in the clinically elevated range on a standardized anxiety and / or depression symptom measure . - Youth lives with a legal guardian (hereafter referred to as "parent") >= 50% of the time who consents to study participation. - Youth speaks English. - Parent speaks English or Spanish. Exclusion Criteria: - Youth requires alternate treatment as indexed by: - current clinically significant Post-Traumatic Stress Disorder symptoms (meets diagnostic criteria in research interview and / or scores in the clinically elevated range on a standardized symptom measure) at baseline. - current suicidal ideation with plan at baseline and / or suicidal behavior within the last year. - current substance dependence at baseline. - experience of physical or sexual abuse within the six months prior to baseline. - parent /guardian does not identify anxiety and / or depression as a treatment priority at baseline. - Youth is in an active, alternate psychosocial intervention for anxiety or depression that would be concurrent with study participation. - Youth is on an unstable regimen of psychotropic medication (i.e., receives medication but has not been at a stable dose for at least 8 weeks, or if medication has been discontinued for less than 4 weeks) at baseline. - Youth is receiving lithium or and anti-psychotic medication at baseline. - Youth is placed in a special education program for greater than 50% of the school day and / or youth school placement is below the second-grade level at baseline. - Youth is placed in foster care at baseline. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
San Diego State University | Kaiser Permanente, OCHIN, Inc. |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Children's Global Assessment Scale (CGAS) | Interviewer-rated youth functioning. Scores range from 1 to 100, and higher score indcate superior functioning. | Measured at baseline (Week 0) and follow-up assessments (Week 16 and Week 32) | |
Primary | Pediatric Anxiety Rating Scale (PARS) | Interviewer-rated symptoms of anxiety disorders, combining parent and youth report | Measured at baseline (Week 0) and follow-up assessments (Week 16 and Week 32). The PARS total severity score ranges from 0 to 30, with higher scores indicating greater anxiety severity. | |
Primary | Children's Depression Rating Scale -- Revised (CDRS-R) | Interviewer rated symptoms of depressive disorders, combining parent and youth report | Measured at baseline (Week 0) and follow-up assessments (Week 16 and Week 32). The CDRS-R total severity score ranges from 17 to 113, with higher scores indicating greater depression symptom severity. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04122482 -
An Online Course for Improving Knowledge and Access to Mental Health Accommodations in Canadian Enterprises
|
N/A | |
Completed |
NCT04085861 -
Mental Health in Dancers; an Intervention Study
|
N/A | |
Recruiting |
NCT06060210 -
Impact of Ketamine On Depressive Symptoms In Patients Undergoing Lumbo-peritoneal Shunt Insertion
|
Phase 4 | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Recruiting |
NCT06065787 -
NeuroGlove Anxiety and Depression Study
|
N/A | |
Active, not recruiting |
NCT04583891 -
Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design
|
N/A | |
Completed |
NCT05554042 -
Kintsugi Voice Device Study
|
||
Not yet recruiting |
NCT06162624 -
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
|
N/A | |
Not yet recruiting |
NCT06430853 -
Psychobiological Interventions in Pregnancy
|
N/A | |
Completed |
NCT02954250 -
Mindfulness Based Cognitive Therapy for Depression and Cognitive Inhibition in Suicide
|
Early Phase 1 | |
Recruiting |
NCT05647499 -
Evaluating the Back 2 School Program in a Norwegian Setting: A Multicenter Pilot Study
|
N/A | |
Completed |
NCT03980873 -
Cognitive-Behavioral Therapy for Young Adult Lesbian, Gay and Bisexual: Transdiagnostic Minority Stress Approach
|
N/A | |
Completed |
NCT04422327 -
The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome
|
Phase 1/Phase 2 | |
Completed |
NCT05368155 -
Chronic Pelvic Pain and Education Skills Training for Women Veterans
|
N/A | |
Completed |
NCT05455905 -
Voice Biomarkers Predictive of Depression and Anxiety
|
||
Completed |
NCT03272516 -
Mindfulness Based Cognitive Therapy (MBCT) for Primary Care Patients
|
N/A | |
Not yet recruiting |
NCT05493865 -
Parent-Child Single-Session Growth Mindset Intervention on Adolescent Depression and Anxiety Problems
|
N/A | |
Not yet recruiting |
NCT06027047 -
Breakthrough Anxiety and Sleep Evaluation Using Linked Devices and Smartphone Application Onar (BASEL)
|
||
Not yet recruiting |
NCT05535101 -
Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder
|
N/A | |
Recruiting |
NCT04418115 -
Fatigue as a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option?
|
N/A |